Hypofractionated Radiotherapy Combined With NALIRIF, PD-1 Antibody in Locally Recurrent Rectal Cancer(NOVELTY-R)

Clinical trial NCT07183865 · RECRUITING

Trial details

NCT number: NCT07183865
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Recurrent Rectal Cancer

Start date: 2025-03-09
Primary completion: 2030-03-09
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.